National Biologic Coordinators Day

United States

About

National Biologic Coordinators Day, observed on November 1, recognizes the dedicated professionals who help manage biologic treatments and support patients receiving them. Working across healthcare teams, biologic coordinators help organize care, communicate important information, and guide patients through treatment processes involving specialized biologic medicines.

This observance is an opportunity to appreciate the knowledge, care, and coordination these professionals bring to patient care. On November 1, take a moment to thank biologic coordinators and other healthcare workers whose behind-the-scenes efforts help make treatment journeys more informed, organized, and compassionate.

History

National Biologic Coordinators Day is observed annually on **November 1** to recognize the professionals who help patients receive and manage biologic therapies. These coordinators commonly work across clinical, administrative, and financial areas: they may educate patients, coordinate prescriptions and infusions, communicate with physicians and specialty pharmacies, monitor treatment requirements, and help patients navigate insurance authorization and assistance programs.

The observance reflects the growing importance of biologic medicines in modern health care. Unlike many conventional drugs, biologics are produced from living sources and may require specialized prescribing, storage, administration, and follow-up. As these therapies became more widely used for conditions such as autoimmune diseases, inflammatory disorders, cancer, and other complex illnesses, health-care systems increasingly relied on coordinators to connect patients, clinicians, pharmacies, manufacturers, and insurers.

Public information about the precise founding of National Biologic Coordinators Day is limited, and no universally documented founder or legislative proclamation is identified in commonly available accounts. Its significance lies primarily in professional recognition: November 1 provides an annual opportunity to acknowledge work that is often performed behind the scenes but can strongly influence whether treatment begins promptly and continues safely.

Culturally, the day highlights the collaborative nature of specialized medical care. It recognizes that successful treatment involves more than developing an effective medicine; patients may also need clear instruction, logistical support, financial guidance, and continuing communication. By honoring biologic coordinators on November 1, the observance draws attention to the patient advocacy and coordination that help make advanced therapies accessible and manageable.

Timeline

1796
Edward Jenner performed his landmark smallpox vaccination experiment using cowpox material, helping establish vaccination as a foundational form of biologic prevention.
1975
Georges Köhler and César Milstein published the hybridoma method for producing monoclonal antibodies, a breakthrough that enabled many modern antibody biologic medicines.
1982
The U.S. Food and Drug Administration approved Humulin, recombinant human insulin produced using genetically engineered bacteria; it was the first approved recombinant-DNA pharmaceutical.
1986
The FDA approved muromonab-CD3 (Orthoclone OKT3), the first monoclonal antibody therapeutic approved for human use.
2017
The FDA approved tisagenlecleucel (Kymriah), the first gene therapy approved in the United States, marking a major milestone for advanced biologic treatments.

Upcoming dates

Sources

Same day

Related